[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Evans et al., 1965 - Google Patents

Studies with radioiodinated cold agglutinins of ten patients

Evans et al., 1965

Document ID
10585445661218575785
Author
Evans R
Turner E
Bingham M
Publication year
Publication venue
The American Journal of Medicine

External Links

Snippet

The incorporation of I 131 into macromolecular cold agglutinins and purification by adsorption and elution from red cell stroma or whole red cells did not modify the serologic characteristics of the agglutinins. The radioiodination permits visualization of the relationship …
Continue reading at www.sciencedirect.com (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/80—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood groups or blood types or red blood cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/536—Immunoassay; Biospecific binding assay with immune complex formed in liquid phase
    • G01N33/537—Immunoassay; Biospecific binding assay with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/564—Immunoassay; Biospecific binding assay for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/72—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood

Similar Documents

Publication Publication Date Title
Evans et al. Studies with radioiodinated cold agglutinins of ten patients
Ham et al. Studies on destruction of red blood cells. II. Chronic hemolytic anemia with paroxysmal nocturnal hemoglobinuria: certain immunological aspects of the hemolytic mechanism with special reference to serum complement
Spiegelberg et al. Catabolism of human γG-immunoglobulins of different heavy chain subclasses: I. Catabolism of γG-myeloma proteins in man
Abramson et al. Deficiency of C3 inactivator in man
Alter et al. Further studies on a" new" human isoprecipitin system (Australia antigen)
Levine et al. The role of iso-immunization in the pathogenesis of erythroblastosis fetalis
Dixon et al. Mechanism of complement-mediated activation of human blood platelets in vitro: comparison of normal and paroxysmal nocturnal hemoglobinuria platelets.
Engelfriet et al. Autoimmune haemolytic anaemias. I. Serological studies with pure anti-immunoglobulin reagents
EVANS et al. The serology of autoimmune hemolytic disease: observations on forty-one patients
Petz et al. In vivo metabolism of complement: I. Metabolism of the third component (C′ 3) in acquired hemolytic anemia
Wahl et al. Thrombocytopenia associated with antiheparin antibody
Evans et al. Chronic hemolytic anemia due to cold agglutinins: the mechanism of resistance of red cells to C′ hemolysis by cold agglutinins
NATELSON et al. Acquired factor IX deficiency in the nephrotic syndrome
Fialkow et al. “Acquired” antibody hemolytic anemia and familial aberrations in gamma globulins
Costea et al. The use of radioactive antiglobulin for the detection of erythrocyte sensitization
Davey et al. The clinical significance of anti‐H in an individual with the Oh (Bombay) phenotype
CORN et al. Evaluation of platelet antibodies in idiopathic thrombocytopenic purpura
LALEZARI et al. Studies on the genetics of leukocyte antigens
Lind et al. Observations on blood glucose and insulin determinations
Nordhagen et al. Paroxysmal cold haemoglobinuria: the most frequent acute autoimmune haemolytic anaemia in children?
Jenkins et al. Serum-red cell interactions at low ionic strength: Erythrocyte complement coating and hemolysis of paroxysmal nocturnal hemoglobinuria cells
Freiesleben et al. Haemolytic Disease of the Newborn Caused by Anti‐M: The Value of the Direct Conglutination Test
Fäldt et al. Heat production in different populations of human blood cells exposed to immune complexes in vitro: the importance of the Fc parts of immunoglobulins and the influence of active complement.
Barrowcliffe et al. Small scale preparation and clinical use of factor IX‐prothrombin complex
Haberman et al. ABO isoimmunization: the use of the specific Coombs and heat elution tests in the detection of hemolytic disease